After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Solid Biosciences Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Solid Biosciences Inc is $461.23M. A total of 1.6 million shares were traded on the day, compared to an average of 1.14M shares.
In the most recent transaction, Howton David T sold 4,932 shares of SLDB for 5.11 per share on Dec 03 ’25. After the transaction, the Chief Operating Officer now owns 32,908 company shares. In a previous transaction on Dec 03 ’25, Cumbo Alexander sold 10,808 shares at 5.11 per share. SLDB shares that President and CEO owns now total 81,388.
Among the insiders who sold shares, Hanrahan Jessie disposed of 4,483 shares on Dec 03 ’25 at a per-share price of $5.11. This resulted in the Chief Regulatory Officer holding 26,660 shares of SLDB after the transaction. In another insider transaction, Herzich Paul sold 2,701 shares at $5.11 per share on Dec 03 ’25. Company shares held by the Chief Technology Officer now total 26,622.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, SLDB has a high of $7.37 and a low of $2.41.
As of this writing, SLDB has an earnings estimate of -$0.5 per share for the current quarter. EPS was calculated based on a consensus of 13.0 estimates, with a high estimate of -$0.38 per share and a lower estimate of -$0.63. The company reported an EPS of -$1 in the last quarter
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. SLDB’s latest balance sheet shows that the firm has $207.78M in Cash & Short Term Investments as of fiscal 2021. There were $2.06M in debt and $23.60M in liabilities at the time. Its Book Value Per Share was $2.80, while its Total Shareholder’s Equity was $208.21M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SLDB is Buy with a score of 4.86.
